摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2',3'-dideoxy-2',3'-didehydro-3'-fluorouridine | 122757-52-2

中文名称
——
中文别名
——
英文名称
2',3'-dideoxy-2',3'-didehydro-3'-fluorouridine
英文别名
Uridine, 2',3'-didehydro-2'-fluoro-;1-[(2R,5S)-3-fluoro-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]pyrimidine-2,4-dione
2',3'-dideoxy-2',3'-didehydro-3'-fluorouridine化学式
CAS
122757-52-2
化学式
C9H9FN2O4
mdl
——
分子量
228.18
InChiKey
SXIDSWOQTOLVOL-YLWLKBPMSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    162-163 °C
  • 密度:
    1.57±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -1.3
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    78.9
  • 氢给体数:
    2
  • 氢受体数:
    5

SDS

SDS:b5ca5f406b4518a766b35b1a45b518f5
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2',3'-dideoxy-2',3'-didehydro-3'-fluorouridine吡啶三乙胺三氯氧磷 作用下, 以 乙腈 为溶剂, 反应 19.0h, 生成 1-(5-O-acetyl-2,3-dideoxy-2-fluoro-β-D-glycero-pent-2-enofuranosyl)-4-(1,2,4-triazo-1-yl)-2-pyrimidinone
    参考文献:
    名称:
    嘧啶脱氧核糖核苷的单氟和二氟类似物的合成及其抗人免疫缺陷病毒(HIV-1)的抗病毒活性。
    摘要:
    合成了一系列嘧啶脱氧核糖核苷的2'-氟和2',3'-二氟类似物,并在人淋巴母细胞样细胞系中针对人免疫缺陷病毒(HIV-1)进行了评估。在这些化合物中,1-(2,3-二脱氧-2-氟-β-D-叔戊基呋喃糖基)胞嘧啶(12),2',3'-二脱氢-2',3'-二脱氧-2'-氟胞苷(35) ),1-(2,3-dideoxy-2,3-difluoro-beta-D-arabinofuranosyl)cytosine(41)和3'-deoxy-2',3'-deidehydro-2'-fluorothymidine(45)为被发现具有显着的抗病毒活性,IC50值分别为0.65、10、10和100 microM。讨论了构效关系。
    DOI:
    10.1021/jm00170a015
  • 作为产物:
    参考文献:
    名称:
    嘧啶脱氧核糖核苷的单氟和二氟类似物的合成及其抗人免疫缺陷病毒(HIV-1)的抗病毒活性。
    摘要:
    合成了一系列嘧啶脱氧核糖核苷的2'-氟和2',3'-二氟类似物,并在人淋巴母细胞样细胞系中针对人免疫缺陷病毒(HIV-1)进行了评估。在这些化合物中,1-(2,3-二脱氧-2-氟-β-D-叔戊基呋喃糖基)胞嘧啶(12),2',3'-二脱氢-2',3'-二脱氧-2'-氟胞苷(35) ),1-(2,3-dideoxy-2,3-difluoro-beta-D-arabinofuranosyl)cytosine(41)和3'-deoxy-2',3'-deidehydro-2'-fluorothymidine(45)为被发现具有显着的抗病毒活性,IC50值分别为0.65、10、10和100 microM。讨论了构效关系。
    DOI:
    10.1021/jm00170a015
点击查看最新优质反应信息

文献信息

  • Nucleic Acid Related Compounds. 91. Biomimetic Reactions Are in Harmony with Loss of 2‘-Substituents as Free Radicals (Not Anions) during Mechanism-Based Inactivation of Ribonucleotide Reductases. Differential Interactions of Azide, Halogen, and Alkylthio Groups with Tributylstannane and Triphenylsilane<sup>1</sup>
    作者:Morris J. Robins、Stanislaw F. Wnuk、Amelia E. Hernández-Thirring、Mirna C. Samano
    DOI:10.1021/ja962117m
    日期:1996.1.1
    The initial step in the mechanism-based inactivation of ribonucleotide reductases by 2'-chloro-2'-deoxynucleotides is abstraction of H3' by a proximal free radical on the enzyme. The C3' radical is postulated to undergo spontaneous loss of chloride, and the resulting cationic radical loses a proton to give a 3'-keto intermediate. Successive beta-eliminations produce a Michael acceptor which causes inactivation. This hypothesis would predict rapid loss of mesylate or tosylate anions from C2', but sluggish loss of azide or thiomethoxide. in contrast, loss of azido and methylthio radicals from C2' should occur readily whereas homolysis to give (methyl or tolylsulfonyl)oxy and fluoro radicals should be energetically prohibitive. Protected 3'-O-(phenoxythiocarbonyl)-2'-substitute nucleosides were treated with tributylstannane/AIBN or triphenylsilane/dibenzoyl peroxide in refluxing toluene. The 2'-O-(mesyl and tosyl) and 2'-fluoro compounds underwent direct radical-mediated hydrogenolysis of the thionocarbonate group to give 3'-deoxy-2'-substituted products, whereas 2'-(azido, bromo, chloro, iodo, and methylthio)-3'-thionocarbonates gave 2',3'-didehydro-2',3'-dideoxy derivatives via loss of 2'-substituents from an incipient C3' radical. These results are in harmony with loss of radicals, but not anions, from C2'. The well-known radical-mediated hydrogenolytic cleavage of halogen and methylthio (slow) groups from C2' of the S'-hydroxy (unprotected) precursors and reduction of 2'-azides to amines occurred with tributylstannane/AIBN. Triphenylsilane/dibenzoyl peroxide gave parallel (but slower) hydrogenolysis with the 2'-(iodo, bromo, and methylthio) compounds, but cleavage of the 2'-chloro group was very slow and no reduction of 2'-azides to amines was detected. Rather, the latter system effected slow hydrogenolytic removal of the 2'-azido group. Thus, chemoselective differentiation of certain functional groups is possible with triphenylsilane and tributylstannane. Reduction of azides to amines with tributylstannane is known, but hydrogenolytic deazidation (slow) with triphenylsilane in the absence of amine formation appears to be novel.
  • MORISAVA, JOSITAMI;OKADZOEH, TAKASI;SUGA, ATSUO;ASAI, TOMOYUKI;YASUDA, AR+
    作者:MORISAVA, JOSITAMI、OKADZOEH, TAKASI、SUGA, ATSUO、ASAI, TOMOYUKI、YASUDA, AR+
    DOI:——
    日期:——
  • MARTIN, JOSEPH A.;BUSHNELL, DAVID J.;DUNCAN, IAN B.;DUNSDON, STEPHEN J.;H+, J. MED. CHEM., 33,(1990) N, C. 2137-2145
    作者:MARTIN, JOSEPH A.、BUSHNELL, DAVID J.、DUNCAN, IAN B.、DUNSDON, STEPHEN J.、H+
    DOI:——
    日期:——
  • Synthesis and antiviral activity of monofluoro and difluoro analogs of pyrimidine deoxyribonucleosides against human immunodeficiency virus (HIV-1)
    作者:Joseph A. Martin、David J. Bushnell、Ian B. Duncan、Stephen J. Dunsdon、Michael J. Hall、Peter J. Machin、John H. Merrett、Kevin E. B. Parkes、Noel A. Roberts
    DOI:10.1021/jm00170a015
    日期:1990.8
    A range of 2'-fluoro and 2',3'-difluoro analogues of pyrimidine deoxyribonucleosides have been synthesized and evaluated against human immunodeficiency virus (HIV-1) in a human lymphoblastoid cell line. Among these compounds, 1-(2,3-dideoxy-2-fluoro-beta-D-threopentofuranosyl)cytosine (12), 2',3'-didehydro-2',3'-dideoxy-2'-fluorocytidine (35), 1-(2,3-dideoxy-2,3-difluoro-beta-D-arabinofuranosyl)cytosine
    合成了一系列嘧啶脱氧核糖核苷的2'-氟和2',3'-二氟类似物,并在人淋巴母细胞样细胞系中针对人免疫缺陷病毒(HIV-1)进行了评估。在这些化合物中,1-(2,3-二脱氧-2-氟-β-D-叔戊基呋喃糖基)胞嘧啶(12),2',3'-二脱氢-2',3'-二脱氧-2'-氟胞苷(35) ),1-(2,3-dideoxy-2,3-difluoro-beta-D-arabinofuranosyl)cytosine(41)和3'-deoxy-2',3'-deidehydro-2'-fluorothymidine(45)为被发现具有显着的抗病毒活性,IC50值分别为0.65、10、10和100 microM。讨论了构效关系。
查看更多

同类化合物

顺式5-氟-1-[2-(羟甲基)-1,3-氧硫杂环戊-5-基]-2,4(1H,3H)-嘧啶二酮-13C,15N2 顺式5-氟-1-[2-(羟甲基)-1,3-氧硫杂环戊-5-基]-2,4(1H,3H)-嘧啶二酮 顺-5-氟-1-[2-[[[[(((1,1-二甲基乙基)二甲基甲硅烷基]氧基]甲基]-1,3-氧杂硫杂环戊-5-基]-2,4(1H,3H)-嘧啶二酮-13C,15N2 顺-5-氟-1-[2-[[[[(((1,1-二甲基乙基)二甲基甲硅烷基]氧基]甲基]-1,3-氧杂硫杂环戊-5-基]-2,4(1H,3H)-嘧啶二酮 阿巴卡韦羧酸盐 阿巴卡韦相关物质D 阿巴卡韦杂质F 阿巴卡韦杂质 阿巴卡韦中间体A5 阿巴卡韦5’-磷酸酯 阿巴卡韦,拉米夫定混合物 阿巴卡韦 芒霉素 艾夫他滨 腺苷基(3'-5')胞苷基(3'-5')胞苷游离酸 脱氧假尿苷 胸苷酰-(5'-3')-胸苷酰-(5'-3')-胸苷酰-(5'-3')-5'-胸苷酸 胰腺癌RX-3117 硫酸阿巴卡韦 甲基磷羧酸氢[(2S,5R)-5-(4-氨基-2-羰基嘧啶-1(2H)-基)-2,5-二氢呋喃-2-基]甲酯 瓶型酵母D 瓶型酵母A 环戊烯基尿嘧啶 水杨酸拉米呋啶 氟达拉滨EP杂质H 曲沙他滨 拉米夫定相关化合物(Α-TROXACITABINE) 拉米夫定杂质Ⅲ1-[(2R,5S)-2-羟甲基-1,3-氧硫杂环戊-5-基]-嘧啶-2,4(1H,3H)-酮 拉米夫定杂质1 拉米夫定S-氧化物(异构体混合物) 拉米夫定 拉米夫定 拉夫米定EP杂质J 拉夫米定EP杂质H 扎西他宾 恩替卡韦相关物质A 恩替卡韦一水合物 恩曲他滨杂质16 恩曲他滨S-氧化物 恩曲他滨 恩曲他滨 怀俄苷三乙酸酯 怀俄苷 己二酸,聚合1,2-丁二醇 外消旋拉米夫定酸 吡唑霉素 司他夫定 反式-阿巴卡韦盐酸盐 卡波啶 卡巴韦